ENTG News and Press, Entegris Inc. From 07/27/21

Entegris (ENTG): Q2 Non-GAAP EPS of $0.85 beats by $0.06; GAAP EPS of $0.65 misses by $0.03.Revenue of $571.35M (+27.4% Y/Y) beats by $33.38M.Q2 gross margin was 46.4% compared to 46.2% in prior quarter, and 45.8% year-ago.The company sees Q3 revenue between $575M to $590M (consensus: $561.28...

Second-quarter revenue of $571 million, increased 27% from prior year Second-quarter GAAP diluted EPS of $0.65, increased 30% Second-quarter non-GAAP diluted EPS of $0.85, increased 42% Entegris , Inc. (NASDAQ: ENTG), today reported its financial resu...

MJ_Prototype/iStock via Getty Images Expecting the stock to continue trading sideways until the Coherent acquisition is closed, Citi downgrades II-VI (IIVI) from Buy to Neutral. "We do not expect meaningful share price expansion until after the deal is closed and synergies are realized, simil...

Entegris , Inc. (NASDAQ: ENTG), will release its financial results for the second quarter of 2021 before the opening of the market on Tuesday, July 27, 2021. A teleconference with management is scheduled for the same day at 9:00 a.m. Eastern Time (ET). Participants should dial +...

Semis ended the first half of 2021 on a strong note, but there were notable differences in Q2 compared to Q1. Not all semis are created equally and a number of semiconductor stocks may be due for a correction as the main factor that helped them rise fades away. Capital is pouring ...

When the healthcare industry is looking for a safe, effective way to produce and distribute vaccines to battle a global pandemic, turning to a processor from the semiconductor industry may not be the first thought for a solution. But when asked a similar question about how gaps in advan...

The time has passed for this cyclical industry, as most strong names now see high valuations. This company exhibits leading fundamentals, and the share price has grown accordingly. I remain hesitant to add shares as growth missed expectations last earnings and current shareholders...

With a diverse range of solutions provided, ESI has seen a pattern of profitability over the past two-years. Although stable growth remains the weak point, the revenue segments point to great long-term prospects and potential. At current prices, the company looks competitively val...

Entegris ([[ENTG]] -0.7%) announces the expansion of its Life Sciences manufacturing facilities located in Billerica, MA; Bloomington, MN; and Logan, UT.The expansions are part of Entegris’ capital expenditures plan to invest about $30M in life sciences capacity and capa...

The expansion of production facilities and development of a dedicated Life Sciences Technology Center address the increased demand for bioprocessing assemblies. Entegris, Inc. (NASDAQ: ENTG), a world-class supplier of advanced materials and process solutions for the semicond...